We brought a newborn screening test to Washington to catch a rare immune disorder when babies are still healthy enough to be cured.
Our surgeons helped create new guidelines to improve diagnosis and treatment for hundreds of children across Washington every year.
A study led by Dr. Doug Hawkins shows that a new chemotherapy protocol greatly reduces side effects for patients with rhabdomyosarcoma.
We’re one of eight children’s hospitals hand-picked to pioneer the linking of patient data systems to speed up medical research.
Extramural awards grew by 21% in 2014 despite intense competition for limited funding. cont.
Partnerships with private companies play a growing role in Seattle Children’s Research Institute’s quest to cure childhood diseases. cont.
Will high dose erythropoietin (Epo) protect extremely premature babies from brain injury?
Seattle Children's researchers are illuminating the huge role a tiny part of the brain may play in depression and moods.
Seattle Children’s researchers show that one way HIV survives antiretroviral treatment is by disrupting genes that control cell proliferation.
Researchers at Seattle Children's seek solutions to the cultural, societal, and systemic issues that impact the health and wellbeing of children.
Academic Annual Report